Our study established a six-gene signature comprising CHMP2B, TRAF2, RIPK3, CXCL1, GPX4, and CHMP6, and a prognostic nomogram, which can reliably predict the overall survival of CRC. The gene discussed is TRAF2; the disease is colorectal carcinoma.